Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ERMEZA

LEVOTHYROXINE SODIUM

Standard Dose
150MCG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ERMEZA is listed in Drugs@FDA under application 215809 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength SOLUTION;ORAL - 150MCG/5ML Sponsor MYLAN Submission history Latest submission status date: 2022-04-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERMEZA is listed in Drugs@FDA under application 215809 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength SOLUTION;ORAL - 150MCG/5ML Sponsor MYLAN Submission history Latest submission status date: 2022-04-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ERMEZA (LEVOTHYROXINE SODIUM) | Drug Monograph | MedicHelpline